Digital inhaler use in chronic lung disease care
Part of Lungs & breathing clinical trials.
This study tests digital inhaler devices that track your medication use and symptoms, to help improve lung disease care. The researchers want to see if these digital tools are practical and helpful for people with conditions like COPD or asthma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed by a doctor with a chronic obstructive lung condition, such as COPD or asthma.
- You currently use a controller inhaler (dry powder or metered-dose) for daily treatment.
- You can speak, read, and understand English.
- You can use a smartphone or tablet for entering symptoms.
- You are not pregnant and are not a prisoner.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smartphone-based program to help people with COPD manage their condition at home. It may help you track symptoms and avoid flare-ups.
This study looks at how well people with COPD or asthma use their inhalers. It aims to understand common problems and find ways to improve treatment adherence.
This study tests a smartphone app designed to help you track and manage your COPD symptoms day-to-day. It includes a small device you use at home to measure your lung function, aiming to help you catch problems early and stay healthier.
This study tests a smartphone app that helps you learn or improve how to use your inhaler correctly. The app provides education and training to make sure you get the most from your medication.
This study tests whether wearable medical devices can help monitor your COPD symptoms at home. You will use a smartphone app and a small chest patch to track your breathing, which may help you and your doctor better manage your condition.
This study tests whether providing inhaler training and phone reminders helps older adults use their medication correctly. You may be eligible if you are 65+, use a metered-dose inhaler, and are being treated for a lung condition.
Hear when a new Chronic Obstructive Airway Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.